Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8617232rdf:typepubmed:Citationlld:pubmed
pubmed-article:8617232lifeskim:mentionsumls-concept:C2752508lld:lifeskim
pubmed-article:8617232lifeskim:mentionsumls-concept:C1325742lld:lifeskim
pubmed-article:8617232lifeskim:mentionsumls-concept:C1167322lld:lifeskim
pubmed-article:8617232lifeskim:mentionsumls-concept:C0040549lld:lifeskim
pubmed-article:8617232lifeskim:mentionsumls-concept:C1521991lld:lifeskim
pubmed-article:8617232lifeskim:mentionsumls-concept:C1519249lld:lifeskim
pubmed-article:8617232lifeskim:mentionsumls-concept:C0003737lld:lifeskim
pubmed-article:8617232lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:8617232lifeskim:mentionsumls-concept:C1553412lld:lifeskim
pubmed-article:8617232lifeskim:mentionsumls-concept:C1548328lld:lifeskim
pubmed-article:8617232lifeskim:mentionsumls-concept:C0075167lld:lifeskim
pubmed-article:8617232pubmed:issue8lld:pubmed
pubmed-article:8617232pubmed:dateCreated1996-6-10lld:pubmed
pubmed-article:8617232pubmed:abstractTextStaphylococcus aureus alpha-toxin is a hydrophilic polypeptide of 293 amino acids that produces heptameric transmembrane pores. During assembly, the formation of a pre-pore precedes membrane permeabilization; the latter is linked to a conformational change in the oligomer. Here, 41 single-cysteine replacement toxin mutants were thiol-specifically labelled with the polarity-sensitive fluorescent probe acrylodan. After oligomerization on membranes, only the mutants with acrylodan attached to residues in the sequence 118-140 exhibited a marked blue shift in the fluorescence emission maximum, indicative of movement of the fluorophore to a hydrophobic environment. Within this region, two functionally distinct parts could be identified. For mutants at positions 126-140, the shifts were partially reversed after membrane solubilization by detergents, indicating a direct interaction of the label with the membrane lipids. Membrane insertion of this sequence occurred together with the final pre-pore to pore transition of the heptamer. Thus residues 126-140 constitute a transmembrane sequence in the pore. With labelled residues 118-124, pre-pore assembly was the critical event to induce the spectral shifts, which persisted after the removal of membrane lipids and hence probably reflects protomer-protomer contacts within the heptamer. Finally, a derivative of the mutant N121C yielded occluded pores which could be opened by reductive reversal of the modification. Therefore this residue probably lines the lumen of the pore.lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:languageenglld:pubmed
pubmed-article:8617232pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:citationSubsetIMlld:pubmed
pubmed-article:8617232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8617232pubmed:statusMEDLINElld:pubmed
pubmed-article:8617232pubmed:monthAprlld:pubmed
pubmed-article:8617232pubmed:issn0261-4189lld:pubmed
pubmed-article:8617232pubmed:authorpubmed-author:BayleyHHlld:pubmed
pubmed-article:8617232pubmed:authorpubmed-author:BhakdiSSlld:pubmed
pubmed-article:8617232pubmed:authorpubmed-author:PalmerMMlld:pubmed
pubmed-article:8617232pubmed:authorpubmed-author:WalkerBBlld:pubmed
pubmed-article:8617232pubmed:authorpubmed-author:WeisserAAlld:pubmed
pubmed-article:8617232pubmed:authorpubmed-author:KehoeMMlld:pubmed
pubmed-article:8617232pubmed:authorpubmed-author:ValevaAAlld:pubmed
pubmed-article:8617232pubmed:issnTypePrintlld:pubmed
pubmed-article:8617232pubmed:day15lld:pubmed
pubmed-article:8617232pubmed:volume15lld:pubmed
pubmed-article:8617232pubmed:ownerNLMlld:pubmed
pubmed-article:8617232pubmed:authorsCompleteYlld:pubmed
pubmed-article:8617232pubmed:pagination1857-64lld:pubmed
pubmed-article:8617232pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:8617232pubmed:meshHeadingpubmed-meshheading:8617232-...lld:pubmed
pubmed-article:8617232pubmed:meshHeadingpubmed-meshheading:8617232-...lld:pubmed
pubmed-article:8617232pubmed:meshHeadingpubmed-meshheading:8617232-...lld:pubmed
pubmed-article:8617232pubmed:meshHeadingpubmed-meshheading:8617232-...lld:pubmed
pubmed-article:8617232pubmed:meshHeadingpubmed-meshheading:8617232-...lld:pubmed
pubmed-article:8617232pubmed:meshHeadingpubmed-meshheading:8617232-...lld:pubmed
pubmed-article:8617232pubmed:meshHeadingpubmed-meshheading:8617232-...lld:pubmed
pubmed-article:8617232pubmed:meshHeadingpubmed-meshheading:8617232-...lld:pubmed
pubmed-article:8617232pubmed:meshHeadingpubmed-meshheading:8617232-...lld:pubmed
pubmed-article:8617232pubmed:meshHeadingpubmed-meshheading:8617232-...lld:pubmed
pubmed-article:8617232pubmed:meshHeadingpubmed-meshheading:8617232-...lld:pubmed
pubmed-article:8617232pubmed:meshHeadingpubmed-meshheading:8617232-...lld:pubmed
pubmed-article:8617232pubmed:meshHeadingpubmed-meshheading:8617232-...lld:pubmed
pubmed-article:8617232pubmed:meshHeadingpubmed-meshheading:8617232-...lld:pubmed
pubmed-article:8617232pubmed:meshHeadingpubmed-meshheading:8617232-...lld:pubmed
pubmed-article:8617232pubmed:meshHeadingpubmed-meshheading:8617232-...lld:pubmed
pubmed-article:8617232pubmed:year1996lld:pubmed
pubmed-article:8617232pubmed:articleTitleMolecular architecture of a toxin pore: a 15-residue sequence lines the transmembrane channel of staphylococcal alpha-toxin.lld:pubmed
pubmed-article:8617232pubmed:affiliationInstitute of Medical Microbiology and Hygiene, University of Mainz, Germany.lld:pubmed
pubmed-article:8617232pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8617232pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:8617232pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8617232lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8617232lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8617232lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8617232lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8617232lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8617232lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8617232lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8617232lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8617232lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8617232lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8617232lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8617232lld:pubmed
More...